Patients Exposed to Hormone-disrupting Chemicals in Some Medical Supplies and Medication
Complete the form below to unlock access to ALL audio articles.
Health care providers may unintentionally expose patients to endocrine-disrupting chemicals (EDCs) by prescribing certain medications and using medical supplies, according to a perspective published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Exposure to EDCs, chemicals that disrupt the body’s natural hormones, is most often associated with industrial pollution, contaminated food and water, or personal and home care products. Less appreciated is the fact that some medications and medical devices also contain these harmful chemicals. This includes both prescribed and over-the-counter medications as well as medical equipment used in the hospital, including among the most vulnerable patients in the neonatal intensive care unit. Unfortunately, most health care providers are unaware of these risks, and patients are unaware of their exposure.
“Through the prescribing of medications and the use of medical supplies, health care providers expose patients to chemicals that can disrupt the body’s natural hormones,” said the study’s lead author, Robert Michael Sargis, M.D., Ph.D., of the University of Illinois at Chicago in Chicago, Ill. “In order to provide ethically sound medical care, the health care community must be made aware of these risks, manufacturers must strive to identify and eliminate endocrine-disrupting chemicals from their products, and patients must be empowered with knowledge and options to make informed decisions that limit their exposure to potentially harmful chemicals. As clinicians, we have an ethical imperative to act on this issue to protect our patients.”
The authors are calling on physicians to become educated about their role in exposing patients to these chemicals. They express the need for better patient education and a commitment on the part of physicians to live up to their ethical mandates to discuss the risks of EDC exposure. Regulatory agencies and manufacturers also need to identify and eliminate EDCs in medications and medical devices and develop safer alternatives.
“As health care providers, we need to do a better job of limiting the threats of chemical exposures to our patients’ health by ending our complicity in mediating those exposures,” Sargis said.
Robert M Sargis, Lisa Anderson-Shaw, Matthew Genco. Unwitting Accomplices: Endocrine Disruptors Confounding Clinical Care. The Journal of Clinical Endocrinology & Metabolism, 2020; DOI: 10.1210/clinem/dgaa358.
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.